World Health Organization. WHO recommends new name for monkeypox disease. In: World Health Organization Website. 2022. https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease. Accessed 24 Dec 2022.
von Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A Pox-like Disease in Cynomolgus Monkeys. Acta Pathologica Microbiologica Scandinavica. 1959;46:156–76.
Article
Google Scholar
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593–7.
CAS
PubMed
PubMed Central
Google Scholar
Breman JG, Kalisa-Ruti SMV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970–79. Bull World Health Organ. 1980;58(2):165–82.
CAS
PubMed
PubMed Central
Google Scholar
Hall A. The Global Eradication of Smallpox. Final Report of the Global Commission for the Certification of Smallpox Eradication. Postgrad Med J. 1982;58:734
Jezek Z, Grab B, Dixon H. Stochastic model for interhuman spread of monkeypox. Am J Epidemiol. 1987;126:1082–92.
Article
CAS
PubMed
Google Scholar
Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17:643–50.
Article
CAS
PubMed
Google Scholar
Update: Multistate Outbreak of Monkeypox—Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. JAMA 2003;290:325–327.
Sukhdeo S, Mishra S, Walmsley S. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC Infect Dis. 2022;22:928.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Past U.S. Cases and Outbreaks. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/outbreak/us-outbreaks.html.
World Health Organization. Multi-country monkeypox outbreak: situation update. In: Disease Outbreak News. 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396. Accessed 15 Jan 2023.
Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19:872–9.
Article
PubMed
PubMed Central
Google Scholar
•• Centersfor Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). 2022 Mpox Outbreak Cases and Data. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html. Accessed 24 Dec 2022. This website provides updated information regarding the epidemiology of the recent 2022 outbreak of mpox.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). 2022 U.S. Map & Case Count. In: Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html. Accessed 10 Feb 2023.
•• Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022. N Engl J Med. 2022;387:679–91. This large international cases series described the clinical presentation and demographics of those affected by the 2022 outbreak.
Article
CAS
PubMed
Google Scholar
Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlovic S, Cordic S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16:531–41.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Mpox Cases by Age and Gender, Race/Ethnicity, and Symptoms. In: Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/poxvirus/monkeypox/response/2022/demographics.html. Accessed 15 Jan 2023.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). U.S. Mpox Case Trends Reported to CDC. In: Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/poxvirus/mpox/response/2022/mpx-trends.html.
World Health Organization. Monkeypox. In: World Health Organization. 2022. https://www.who.int/news-room/fact-sheets/detail/monkeypox. Accessed 15 Jan 2023.
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16: e0010141.
Article
PubMed
PubMed Central
Google Scholar
Tarín-Vicente E, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. The Lancet. 2022. https://doi.org/10.1016/S0140-6736(22)01436-2.
Article
PubMed
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). How It Spreads. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/if-sick/transmission.html. Accessed 15 Jan 2023.
Lapa D, Carletti F, Mazzotta V, et al. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding. Lancet Infect Dis. 2022;22:1267–9.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Case Definitions for Use in the 2022 Mpox Response. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/case-definition.html. Accessed 15 Jan 2023.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Clinical Recognition: Key Characteristics for Identifying Mpox. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/clinical-recognition.html. Accessed 15 Jan 2023.
Dashraath P, Nielsen-Saines K, Rimoin A, Mattar CNZ, Panchaud A, Baud D. Monkeypox in pregnancy: virology, clinical presentation, and obstetric management. Am J Obstet Gynecol. 2022;227:849-861.e7.
Article
PubMed
Google Scholar
Long B, Liang SY, Carius BM, Chavez S, Gottlieb M, Koyfman A, Brady WJ. Mimics of Monkeypox: Considerations for the emergency medicine clinician. Am J Emerg Med. 2023;65:172–8.
Article
PubMed
PubMed Central
Google Scholar
Rimoin A, Kisalu N, Ilunga B, et al. Endemic Human Monkeypox, Democratic Republic of Congo, 2001–2004. Emerg Infect Dis. 2007;13:934–7.
Article
PubMed
PubMed Central
Google Scholar
Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401:939–49.
Article
PubMed
Google Scholar
• Centersfor Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Guidelines for Collecting and Handling Specimens for Mpox Testing. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/prep-collection-specimens.html. Accessed 15 Jan 2022. This website provides guidelines regarding how to properly test patients for mpox.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Non-Variola Orthopoxvirus and Mpox Virus Laboratory Testing Data. In: Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/poxvirus/monkeypox/response/2022/2022-lab-test.html. Accessed 10 Feb 2023
Minhaj FS, Petras JK, Brown JA, et al. Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox — United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1155–8.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Clinical Considerations for Pain Management of Mpox. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/pain-management.html.
• Centersfor Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Interim Clinical Guidance for the Treatment of Mpox. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html#anchor_1655488137245. Accessed 10 Feb 2023. This website provides up to date information for clinicians regarding how to treat mpox.
O’Laughlin K, Tobolowsky FA, Elmor R, et al. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May- August 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1190–5.
Article
PubMed
PubMed Central
Google Scholar
Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox. Antiviral Res. 2017;143:269–77.
Article
CAS
PubMed
Google Scholar
Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and Treatment of Monkeypox. Drugs. 2022;82:957–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Infection Prevention and Control of Mpox in Healthcare Settings. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/infection-control-healthcare.html. Accessed 15 Jan 2023
• Payne A, Ray L, Kugeler K, et al. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022. MMWR Morbidity and Mortality Weekly Report. 2022. https://doi.org/10.15585/mmwr.mm7140e3. This is the first study examining the safety profile and effectiveness of the JYNEEOS vaccine for the prevention of mpox.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Components of the U.S. National Mpox Vaccination Strategy. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/interim-considerations/overview.html#components. Accessed 21 Jan 2023.
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Vaccination Considerations for Specific Populations. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/poxvirus/monkeypox/interim-considerations/special-populations.html. Accessed 21 Jan 2023.
留言 (0)